Register to receive a free U.S. Market for Surgical Navigation Systems and Robotics report synopsis and brochure
When blood vessels are working properly, you don’t give them a thought. But when they are blocked or feeding a tumor or fibroid, they can cause symptoms that range from annoying to painful, embarrassing to life-threatening. Surgery can fix the problem, sometimes. However, it often doesn’t work, and in overly complicated cases, may not even be an option.
Now a new robotic system allows physicians to reach and fix vessels in minimally-invasive vascular procedures that produce better results, quicker recovery times and fewer side effects than open surgery. Holy Name Medical Center (HNMC) is the first in the Northeast to have the Magellan Robotic System, which guides very small catheters that can be controlled to bend and twist in any direction needed to navigate the most complex of vascular systems. It is life-changing for many patients, enabling doctors to restore blood flow to legs with painful arterial obstruction, fix complex aneurysms in the body, and selectively cut off the blood supply feeding tumors and fibroids.
“We are able to do these complicated procedures because the Magellan gives us pin-point precision and accuracy,” said John Rundback, MD, director of the Interventional Institute at Holy Name. “We have maximum flexibility and control, giving our patients the best possible outcomes for conditions and diseases that in the past would have been difficult or impossible to treat without surgery and potentially allow successful results for patients who were told that they were unable to be treated.”
But with the Magellan system, doctors use image-guided navigation and have complete maneuverability. The system has catheters and other instruments that rotate 360 degrees and bend 180 degrees in any direction. Doctors at Holy Name are also working with researchers to design catheters specifically created to treat problems involving increasingly small blood vessels, which are the most difficult to treat and when blocked, impair blood flow to the legs. This condition, called critical limb ischemia, or CLI, can cause constant pain or wounds.
“My first procedure with Magellan was on a 64-year-old man with CLI, which was causing him excruciating pain,” Dr. Rundback said. “His blood vessels were extremely twisted and previous procedures were unsuccessful. I was able to get in and successfully navigate all the twists and turns, correct the condition and eliminate the pain he had been living with for years.”
In addition to treating peripheral vascular disease — a narrowing of the vessels that carry blood to the arms, legs, stomach and kidneys — the Magellan is also used to block the blood supply to cancers in the liver and uterine fibroids. And with the same approach, physicians are experimenting with the Magellan to block blood flow — a lifeline — to surgically unremovable head and neck tumors, gynecologic cancers and enlarged prostates. This controlled blocking of the blood can shrink tumors, reduce prostate size and relieve symptoms.
For Further Information
More on the markets for surgical navigation systems in the U.S. can be found in this latest edition report published by iData entitled U.S. Market for Surgical Navigation Systems and Robotics, which covers the U.S. as a whole, as well as market segments for neurosurgery, spine, ENT, and orthopedic navigation systems; spine, neuro, radio, and orthopedic surgery robotic assisted systems; MIS robotic devices; and robotic catheter systems. The report also includes detailed procedure number data.
Full iData reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for an U.S. Market for Surgical Navigation Systems and Robotics report brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.